Potpara T S, Lip G Y H
Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Int J Clin Pract. 2014 Apr;68(4):418-33. doi: 10.1111/ijcp.12281. Epub 2013 Dec 22.
Atrial fibrillation (AF) sometimes develops in younger individuals without any evident cardiac or other disease. To refer to these patients who were considered to have a very favourable prognosis compared with other AF patients, the term 'lone' AF was introduced in 1953. However, there are numerous uncertainties associated with 'lone' AF, including inconsistent entity definitions, considerable variations in the reported prevalence and outcomes, etc. Indeed, increasing evidence suggests a number of often subtle cardiac alterations associated with apparently 'lone' AF, which may have relevant prognostic implications. Hence, 'lone' AF patients comprise a rather heterogeneous cohort, and may have largely variable risk profiles based on the presence (or absence) of overlooked subclinical cardiovascular risk factors or genetically determined subtle alterations at the cellular or molecular level. Whether the implementation of various cardiac imaging techniques, biomarkers and genetic information could improve the prediction of risk for incident AF and risk assessment of 'lone' AF patients, and influence the treatment decisions needs further research. In this review, we summarise the current knowledge on 'lone' AF, highlight the existing inconsistencies in the field and discuss the prognostic and treatment implications of recent insights in 'lone' AF pathophysiology.
心房颤动(AF)有时会在没有任何明显心脏疾病或其他疾病的年轻个体中发生。为了指代这些与其他房颤患者相比被认为预后非常良好的患者,1953年引入了“孤立性”房颤这一术语。然而,“孤立性”房颤存在许多不确定性,包括实体定义不一致、报道的患病率和结局差异很大等。事实上,越来越多的证据表明,一些通常较为细微的心脏改变与明显的“孤立性”房颤相关,这可能具有相关的预后意义。因此,“孤立性”房颤患者构成了一个相当异质性的队列,并且可能基于是否存在被忽视的亚临床心血管危险因素或细胞或分子水平上由基因决定的细微改变而具有很大不同的风险特征。各种心脏成像技术、生物标志物和基因信息的应用是否能够改善对新发房颤风险的预测以及对“孤立性”房颤患者的风险评估,并影响治疗决策,尚需进一步研究。在本综述中,我们总结了关于“孤立性”房颤的现有知识,强调了该领域目前存在的不一致之处,并讨论了“孤立性”房颤病理生理学最新见解的预后和治疗意义。